Sunday, May 09, 2021 9:34:33 AM
What is the point to performing randomization and blinding? What is more blind than this double or even triple blind? What is randomization and why is it important?
Step 1: Collect multiple placebo treated cohorts from similarly captured criteria and check their concordance.
Note: Criteria need not be exact as it will be pooled to create diversity.
Step 2: Group cohorts into a super cohort of randomized placebo patients
Step 2b: Randomly sample from super cohort and test sampling vs super cohort for internal validation
Step 3: Externally validate super cohort against two failed treatment groups
Step 4: Break trial patients and super cohort patients into groups based on risk factor buckets and determine their relative weighting.
Step 5: Retain trial placebo non-crossovers for internal validation of sampled cohort.
Step 6: Add original remaining placebo to matched, sampled, validated (internally - externally x2 - internally once again) cohort for new comparison cohort
Step 7: Compare original randomly selected treatment arm to randomly captured, blindly selected, placebo matched cohort
Step 8: Repeat process for sensitivity analysis
How does this sound to you colleague, regulator, fill in the blank?
———————————————————————————————
Please see below statement and apply to any linked messages...
These are all my opinion and I am not giving anyone anywhere investment advice. Invest at your own risk. I am painting pictures and asking questions to seek answers from others here. I share stories, experience and opinion which at times may be persuasive, but you should not take any of these as advice to you about anything that should be discussed with your broker, investment advisor, physician, or other professional. This stands for all of my posts past, present and future.
Please do not take any statements that seem declarative or that have not been backed by links to facts as facts. They may be subject to a number of errors, including bias and false assumptions. Please understand that I own NWBO stock and assume I own any other marketable equity I discuss and apply the above statements.
You should invest at your own risk. You should seek medical advice from your own doctor. And you should not trust everything that you read from anyone standing behind an alias. I do not know what will happen in the future and do not claim to have the authority to provide any of the above.
I have provided postings in good faith and my views and opinions are expressed in good faith. Emotion can be involved in my posts which to are added in good faith. Please take this statement as such and I very much do appreciate the advice.
Step 1: Collect multiple placebo treated cohorts from similarly captured criteria and check their concordance.
Note: Criteria need not be exact as it will be pooled to create diversity.
Step 2: Group cohorts into a super cohort of randomized placebo patients
Step 2b: Randomly sample from super cohort and test sampling vs super cohort for internal validation
Step 3: Externally validate super cohort against two failed treatment groups
Step 4: Break trial patients and super cohort patients into groups based on risk factor buckets and determine their relative weighting.
Step 5: Retain trial placebo non-crossovers for internal validation of sampled cohort.
Step 6: Add original remaining placebo to matched, sampled, validated (internally - externally x2 - internally once again) cohort for new comparison cohort
Step 7: Compare original randomly selected treatment arm to randomly captured, blindly selected, placebo matched cohort
Step 8: Repeat process for sensitivity analysis
How does this sound to you colleague, regulator, fill in the blank?
———————————————————————————————
Please see below statement and apply to any linked messages...
These are all my opinion and I am not giving anyone anywhere investment advice. Invest at your own risk. I am painting pictures and asking questions to seek answers from others here. I share stories, experience and opinion which at times may be persuasive, but you should not take any of these as advice to you about anything that should be discussed with your broker, investment advisor, physician, or other professional. This stands for all of my posts past, present and future.
Please do not take any statements that seem declarative or that have not been backed by links to facts as facts. They may be subject to a number of errors, including bias and false assumptions. Please understand that I own NWBO stock and assume I own any other marketable equity I discuss and apply the above statements.
You should invest at your own risk. You should seek medical advice from your own doctor. And you should not trust everything that you read from anyone standing behind an alias. I do not know what will happen in the future and do not claim to have the authority to provide any of the above.
I have provided postings in good faith and my views and opinions are expressed in good faith. Emotion can be involved in my posts which to are added in good faith. Please take this statement as such and I very much do appreciate the advice.
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
